» Articles » PMID: 8277372

Tissue Iron Loading and Histopathological Changes in Hypotransferrinaemic Mice

Overview
Journal J Pathol
Specialty Pathology
Date 1993 Nov 1
PMID 8277372
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue iron loading in hypotransferrinaemic (hpx/hpx) mice was investigated as a model for genetic (primary) haemochromatosis. Iron loading of liver preceded that in the pancreas and heart. One-year-old hpx/hpx mice showed iron staining in exocrine pancreas, liver parenchymal cells, and cardiac and intestinal smooth muscle cells. Iron-loaded macrophages were observed in all these tissues. Islets of Langerhans, biliary epithelial cells, and spleen were iron-free. The pancreas was fibrotic with massive macrophage infiltration and loss of secretory epithelium. Liver showed evidence of chronic inflammatory infiltration with increased collagen fibres in the parenchymal region but no cirrhosis. Serum aspartate aminotransferase activity and plasma glucose were increased in hpx/hpx compared with wild-type mice. Heavy iron loading with haemosiderin deposition in the liver could be demonstrated in hpx/hpx mice from 6 weeks of age. Heterozygous hypotransferrinaemic mice showed minor increases in liver iron stores at 6-12 weeks, but not at 1 year of age. Serum ferritin levels in heterozygous mice were also increased at 6-8 weeks of age. It was concluded that 1-year-old hpx/hpx mice showed evidence of liver and pancreatic damage secondary to tissue iron overload. The iron loading pattern and tissue damage showed some features which were distinct from those observed in haemochromatosis.

Citing Articles

Ceruloplasmin and hephaestin jointly protect the exocrine pancreas against oxidative damage by facilitating iron efflux.

Chen M, Zheng J, Liu G, Xu E, Wang J, Fuqua B Redox Biol. 2018; 17:432-439.

PMID: 29883959 PMC: 6007082. DOI: 10.1016/j.redox.2018.05.013.


Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Berridge B, Mowat V, Nagai H, Nyska A, Okazaki Y, Clements P J Toxicol Pathol. 2016; 29(3 Suppl):1S-47S.

PMID: 27621537 PMC: 5013710. DOI: 10.1293/tox.29.3S-1.


Iron uptake and transport across physiological barriers.

Duck K, Connor J Biometals. 2016; 29(4):573-91.

PMID: 27457588 PMC: 4972853. DOI: 10.1007/s10534-016-9952-2.


Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.

Garbowski M, Ma Y, Fucharoen S, Srichairatanakool S, Hider R, Porter J Transl Res. 2016; 177:19-30.e5.

PMID: 27344508 PMC: 5110642. DOI: 10.1016/j.trsl.2016.05.005.


The use of hypotransferrinemic mice in studies of iron biology.

Bu J, Bartnikas T Biometals. 2015; 28(3):473-80.

PMID: 25663418 PMC: 4430341. DOI: 10.1007/s10534-015-9833-0.